Methods for determining the survival potential of cancer patients and for predicting the likelihood of metastasis in cancer patients

摘要

The present invention relates generally to methods of accurately quantifying HER2 and/or p95 expression in subjects with a HER2 positive cancer and indicating the risk of brain relapse in such patients.